Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1997 Jun;50(3):113–123. doi: 10.1136/mp.50.3.113

Functional and clinical aspects of the myelomonocyte protein calprotectin.

B Johne 1, M K Fagerhol 1, T Lyberg 1, H Prydz 1, P Brandtzaeg 1, C F Naess-Andresen 1, I Dale 1
PMCID: PMC379605  PMID: 9292145

Full text

PDF
113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson K. B., Sletten K., Berntzen H. B., Dale I., Brandtzaeg P., Jellum E., Fagerhol M. K. The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol. 1988 Aug;28(2):241–245. doi: 10.1111/j.1365-3083.1988.tb02437.x. [DOI] [PubMed] [Google Scholar]
  2. Andersson K. B., Sletten K., Berntzen H. B., Fagerhol M. K., Dale I., Brandtzaeg P., Jellum E. Leukocyte L1 protein and the cystic fibrosis antigen. Nature. 1988 Apr 21;332(6166):688–688. doi: 10.1038/332688a0. [DOI] [PubMed] [Google Scholar]
  3. Belenko M., Chanana A. D., Joel D. D., Fagerhol M. K., Janoff A. Tracing the leukocyte marker protein in lung fluids and lung-draining lymph nodes during endotoxemia in sheep. Am Rev Respir Dis. 1986 May;133(5):866–874. [PubMed] [Google Scholar]
  4. Bengis-Garber C., Gruener N. Calcium-binding myeloid protein (P8,14) is phosphorylated in fMet-Leu-Phe-stimulated neutrophils. J Leukoc Biol. 1993 Aug;54(2):114–118. doi: 10.1002/jlb.54.2.114. [DOI] [PubMed] [Google Scholar]
  5. Berner Berntzen H., Endresen G. K., Fagerhol M. K., Spiechowicz J., Mowinckel P. Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis. Scand J Clin Lab Invest. 1991 Nov;51(7):643–650. doi: 10.3109/00365519109104575. [DOI] [PubMed] [Google Scholar]
  6. Berntzen H. B., Fagerhol M. K. L1, a major granulocyte protein: antigenic properties of its subunits. Scand J Clin Lab Invest. 1988 Nov;48(7):647–652. [PubMed] [Google Scholar]
  7. Berntzen H. B., Fagerhol M. K. L1, a major granulocyte protein; isolation of high quantities of its subunits. Scand J Clin Lab Invest. 1990 Nov;50(7):769–774. doi: 10.1080/00365519009091071. [DOI] [PubMed] [Google Scholar]
  8. Berntzen H. B., Munthe E., Fagerhol M. K. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol. 1989 Nov;16(11):1416–1420. [PubMed] [Google Scholar]
  9. Bjerke K., Halstensen T. S., Jahnsen F., Pulford K., Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut. 1993 Oct;34(10):1357–1363. doi: 10.1136/gut.34.10.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brandtzaeg P., Dale I., Fagerhol M. K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am J Clin Pathol. 1987 Jun;87(6):681–699. doi: 10.1093/ajcp/87.6.681. [DOI] [PubMed] [Google Scholar]
  11. Brandtzaeg P., Dale I., Fagerhol M. K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol. 1987 Jun;87(6):700–707. doi: 10.1093/ajcp/87.6.700. [DOI] [PubMed] [Google Scholar]
  12. Brandtzaeg P., Dale I., Gabrielsen T. O. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology. 1992 Aug;21(2):191–196. doi: 10.1111/j.1365-2559.1992.tb00374.x. [DOI] [PubMed] [Google Scholar]
  13. Brandtzaeg P., Gabrielsen T. O., Dale I., Müller F., Steinbakk M., Fagerhol M. K. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol. 1995;371A:201–206. doi: 10.1007/978-1-4615-1941-6_41. [DOI] [PubMed] [Google Scholar]
  14. Brandtzaeg P., Jones D. B., Flavell D. J., Fagerhol M. K. Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J Clin Pathol. 1988 Sep;41(9):963–970. doi: 10.1136/jcp.41.9.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Brun J. G., Cuida M., Jacobsen H., Kloster R., Johannesen A. C., Høyeraal H. M., Jonsson R. Sjögren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva. Scand J Rheumatol. 1994;23(3):114–118. doi: 10.3109/03009749409103041. [DOI] [PubMed] [Google Scholar]
  16. Brun J. G., Haga H. J., Bøe E., Kallay I., Lekven C., Berntzen H. B., Fagerhol M. K. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol. 1992 Jun;19(6):859–862. [PubMed] [Google Scholar]
  17. Brun J. G., Håland G., Haga H. J., Fagerhol M. K., Jonsson R. Effects of calprotectin in avridine-induced arthritis. APMIS. 1995 Mar;103(3):233–240. doi: 10.1111/j.1699-0463.1995.tb01100.x. [DOI] [PubMed] [Google Scholar]
  18. Brun J. G., Ulvestad E., Fagerhol M. K., Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol. 1994 Dec;40(6):675–680. doi: 10.1111/j.1365-3083.1994.tb03523.x. [DOI] [PubMed] [Google Scholar]
  19. Clark B. R., Kelly S. E., Fleming S. Calgranulin expression and association with the keratinocyte cytoskeleton. J Pathol. 1990 Jan;160(1):25–30. doi: 10.1002/path.1711600107. [DOI] [PubMed] [Google Scholar]
  20. Clohessy P. A., Golden B. E. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol. 1995 Nov;42(5):551–556. doi: 10.1111/j.1365-3083.1995.tb03695.x. [DOI] [PubMed] [Google Scholar]
  21. Clohessy P. A., Golden B. E. The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation. Biochem Soc Trans. 1996 May;24(2):309S–309S. doi: 10.1042/bst024309s. [DOI] [PubMed] [Google Scholar]
  22. Coleman N., Stanley M. A. Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix. Hum Pathol. 1994 Jan;25(1):73–79. doi: 10.1016/0046-8177(94)90174-0. [DOI] [PubMed] [Google Scholar]
  23. Cuida M., Brun J. G., Tynning T., Jonsson R. Calprotectin levels in oral fluids: the importance of collection site. Eur J Oral Sci. 1995 Feb;103(1):8–10. doi: 10.1111/j.1600-0722.1995.tb00003.x. [DOI] [PubMed] [Google Scholar]
  24. Dale I., Brandtzaeg P. Expression of the epithelial L1 antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology. 1989 May;14(5):493–502. doi: 10.1111/j.1365-2559.1989.tb02185.x. [DOI] [PubMed] [Google Scholar]
  25. Dale I., Brandtzaeg P., Fagerhol M. K., Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985 Jul;84(1):24–34. doi: 10.1093/ajcp/84.1.24. [DOI] [PubMed] [Google Scholar]
  26. Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand J Clin Lab Invest. 1990 Dec;50(8):837–841. doi: 10.3109/00365519009104950. [DOI] [PubMed] [Google Scholar]
  27. Delabie J., de Wolf-Peeters C., van den Oord J. J., Desmet V. J. Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study. Clin Exp Immunol. 1990 Jul;81(1):123–126. doi: 10.1111/j.1365-2249.1990.tb05301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dell'Angelica E. C., Schleicher C. H., Santomé J. A. Primary structure and binding properties of calgranulin C, a novel S100-like calcium-binding protein from pig granulocytes. J Biol Chem. 1994 Nov 18;269(46):28929–28936. [PubMed] [Google Scholar]
  29. Dianoux A. C., Stasia M. J., Garin J., Gagnon J., Vignais P. V. The 23-kilodalton protein, a substrate of protein kinase C, in bovine neutrophil cytosol is a member of the S100 family. Biochemistry. 1992 Jun 30;31(25):5898–5905. doi: 10.1021/bi00140a028. [DOI] [PubMed] [Google Scholar]
  30. Dorin J. R., Emslie E., van Heyningen V. Related calcium-binding proteins map to the same subregion of chromosome 1q and to an extended region of synteny on mouse chromosome 3. Genomics. 1990 Nov;8(3):420–426. doi: 10.1016/0888-7543(90)90027-r. [DOI] [PubMed] [Google Scholar]
  31. Dorin J. R., Novak M., Hill R. E., Brock D. J., Secher D. S., van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature. 1987 Apr 9;326(6113):614–617. doi: 10.1038/326614a0. [DOI] [PubMed] [Google Scholar]
  32. Dunlop O., Bruun J. N., Myrvang B., Fagerhol M. K. Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection? Scand J Infect Dis. 1991;23(6):687–689. doi: 10.3109/00365549109024294. [DOI] [PubMed] [Google Scholar]
  33. Edgeworth J. D., Abiose A., Jones B. R. An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus. Clin Exp Immunol. 1993 Apr;92(1):84–92. doi: 10.1111/j.1365-2249.1993.tb05952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Eversole L. R., Miyasaki K. T., Christensen R. E. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med. 1993 Aug;22(7):303–307. doi: 10.1111/j.1600-0714.1993.tb01077.x. [DOI] [PubMed] [Google Scholar]
  35. Eversole L. R., Miyasaki K. T., Christensen R. E. The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes. Arch Oral Biol. 1992 Nov;37(11):963–968. doi: 10.1016/0003-9969(92)90068-j. [DOI] [PubMed] [Google Scholar]
  36. Fanjul M., Renaud W., Merten M., Guy-Crotte O., Hollande E., Figarella C. Presence of MRP8 and MRP14 in pancreatic cell lines: differential expression and localization in CFPAC-1 cells. Am J Physiol. 1995 May;268(5 Pt 1):C1241–C1251. doi: 10.1152/ajpcell.1995.268.5.C1241. [DOI] [PubMed] [Google Scholar]
  37. Fosse E., Moen O., Johnson E., Semb G., Brockmeier V., Mollnes T. E., Fagerhol M. K., Venge P. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1994 Aug;58(2):472–477. doi: 10.1016/0003-4975(94)92231-4. [DOI] [PubMed] [Google Scholar]
  38. Freemont P., Hogg N., Edgeworth J. Sequence identity. Nature. 1989 Jun 15;339(6225):516–516. doi: 10.1038/339516b0. [DOI] [PubMed] [Google Scholar]
  39. GIANETTO R., DE DUVE C. Tissue fractionation studies. 4. Comparative study of the binding of acid phosphatase, beta-glucuronidase and cathepsin by rat-liver particles. Biochem J. 1955 Mar;59(3):433–438. doi: 10.1042/bj0590433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gabrielsen T. O., Dale I., Brandtzaeg P., Hoel P. S., Fagerhol M. K., Larsen T. E., Thune P. O. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. J Am Acad Dermatol. 1986 Aug;15(2 Pt 1):173–179. doi: 10.1016/s0190-9622(86)70152-7. [DOI] [PubMed] [Google Scholar]
  41. Garred P., Fosse E., Fagerhol M. K., Videm V., Mollnes T. E. Calprotectin and complement activation during major operations with or without cardiopulmonary bypass. Ann Thorac Surg. 1993 Mar;55(3):694–699. doi: 10.1016/0003-4975(93)90277-o. [DOI] [PubMed] [Google Scholar]
  42. Gilbert J. A., Ahlquist D. A., Mahoney D. W., Zinsmeister A. R., Rubin J., Ellefson R. D. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. Scand J Gastroenterol. 1996 Oct;31(10):1001–1005. doi: 10.3109/00365529609003120. [DOI] [PubMed] [Google Scholar]
  43. Golden B. E., Clohessy P. A., Russell G., Fagerhol M. K. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child. 1996 Feb;74(2):136–139. doi: 10.1136/adc.74.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Guignard F., Mauel J., Markert M. Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur J Biochem. 1996 Oct 1;241(1):265–271. doi: 10.1111/j.1432-1033.1996.0265t.x. [DOI] [PubMed] [Google Scholar]
  46. Guignard F., Mauël J., Markert M. The monoclonal antibody Mac 387 recognizes three S100 proteins in human neutrophils. Immunol Cell Biol. 1996 Feb;74(1):105–107. doi: 10.1038/icb.1996.14. [DOI] [PubMed] [Google Scholar]
  47. Haga H. J., Brun J. G., Berntzen H. B., Cervera R., Khamashta M., Hughes G. R. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus. 1993 Feb;2(1):47–50. doi: 10.1177/096120339300200108. [DOI] [PubMed] [Google Scholar]
  48. Hammer H. B., Kvien T. K., Glennås A., Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol. 1995 Jan-Feb;13(1):59–64. [PubMed] [Google Scholar]
  49. Hessian P. A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol. 1993 Feb;53(2):197–204. [PubMed] [Google Scholar]
  50. Hessian P. A., Wilkinson L., Hogg N. The S100 family protein MRP-14 (S100A9) has homology with the contact domain of high molecular weight kininogen. FEBS Lett. 1995 Sep 11;371(3):271–275. doi: 10.1016/0014-5793(95)00905-o. [DOI] [PubMed] [Google Scholar]
  51. Hetland G., Berntzen H. B., Fagerhol M. K. Levels of calprotectin (leukocyte L1 protein) during apheresis. Scand J Clin Lab Invest. 1992 Oct;52(6):479–482. doi: 10.3109/00365519209090124. [DOI] [PubMed] [Google Scholar]
  52. Hjortdahl P., Landaas S., Urdal P., Steinbakk M., Fuglerud P., Nygaard B. C-reactive protein: a new rapid assay for managing infectious disease in primary health care. Scand J Prim Health Care. 1991 Mar;9(1):3–10. doi: 10.3109/02813439109026574. [DOI] [PubMed] [Google Scholar]
  53. Holt J., Fagerhol M. K., Dale I. Quantitation of a leukocyte protein (L1) in urine. Acta Paediatr Scand. 1983 Jul;72(4):615–616. doi: 10.1111/j.1651-2227.1983.tb09781.x. [DOI] [PubMed] [Google Scholar]
  54. Homann C., Garred P., Graudal N., Hasselqvist P., Christiansen M., Fagerhol M. K., Thomsen A. C. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis. Hepatology. 1995 Apr;21(4):979–985. [PubMed] [Google Scholar]
  55. Hu S. P., Harrison C., Xu K., Cornish C. J., Geczy C. L. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood. 1996 May 1;87(9):3919–3928. [PubMed] [Google Scholar]
  56. Ivanov G. E., Misuno N. I., Ivanov V. E. Enzyme-linked immunosorbent assay for human MRP-8/MRP-14 proteins and their quantitation in plasma of hematological patients. Immunol Lett. 1996 Jan;49(1-2):7–13. doi: 10.1016/0165-2478(95)02472-7. [DOI] [PubMed] [Google Scholar]
  57. Johne B., Hansen K., Mørk E., Holtlund J. Colloidal gold conjugated monoclonal antibodies, studied in the BIAcore biosensor and in the Nycocard immunoassay format. J Immunol Methods. 1995 Jun 14;183(1):167–174. doi: 10.1016/0022-1759(95)00047-e. [DOI] [PubMed] [Google Scholar]
  58. Kelly S. E., Hunter J. A., Jones D. B., Clark B. R., Fleming S. Morphological evidence for calcium-dependent association of calgranulin with the epidermal cytoskeleton in inflammatory dermatoses. Br J Dermatol. 1991 May;124(5):403–409. doi: 10.1111/j.1365-2133.1991.tb00616.x. [DOI] [PubMed] [Google Scholar]
  59. Kelly S. E., Jones D. B., Fleming S. Calgranulin expression in inflammatory dermatoses. J Pathol. 1989 Sep;159(1):17–21. doi: 10.1002/path.1711590107. [DOI] [PubMed] [Google Scholar]
  60. Kjeldsen-Kragh J., Mellbye O. J., Haugen M., Mollnes T. E., Hammer H. B., Sioud M., Førre O. Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet. Scand J Rheumatol. 1995;24(2):85–93. doi: 10.3109/03009749509099290. [DOI] [PubMed] [Google Scholar]
  61. Kligman D., Hilt D. C. The S100 protein family. Trends Biochem Sci. 1988 Nov;13(11):437–443. doi: 10.1016/0968-0004(88)90218-6. [DOI] [PubMed] [Google Scholar]
  62. Kocher M., Kenny P. A., Farram E., Abdul Majid K. B., Finlay-Jones J. J., Geczy C L. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses. Infect Immun. 1996 Apr;64(4):1342–1350. doi: 10.1128/iai.64.4.1342-1350.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Lagasse E., Clerc R. G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol. 1988 Jun;8(6):2402–2410. doi: 10.1128/mcb.8.6.2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Lehrer R. I. Holocrine secretion of calprotectin: a neutrophil-mediated defense against Candida albicans? J Lab Clin Med. 1993 Feb;121(2):193–194. [PubMed] [Google Scholar]
  65. Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol. 1996 May;56(5):263–277. doi: 10.1111/j.1600-0609.1996.tb00714.x. [DOI] [PubMed] [Google Scholar]
  66. Loftus B., Loh L. C., Curran B., Henry K., Leader M. Mac387: its non-specificity as a tumour marker or marker of histiocytes. Histopathology. 1991 Sep;19(3):251–255. doi: 10.1111/j.1365-2559.1991.tb00030.x. [DOI] [PubMed] [Google Scholar]
  67. Longbottom D., Sallenave J. M., van Heyningen V. Subunit structure of calgranulins A and B obtained from sputum, plasma, granulocytes and cultured epithelial cells. Biochim Biophys Acta. 1992 Apr 8;1120(2):215–222. doi: 10.1016/0167-4838(92)90273-g. [DOI] [PubMed] [Google Scholar]
  68. Lügering N., Stoll R., Kucharzik T., Burmeister G., Sorg C., Domschke W. Serum 27E10 antigen: a new potential marker for staging HIV disease. Clin Exp Immunol. 1995 Aug;101(2):249–253. doi: 10.1111/j.1365-2249.1995.tb08346.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Lügering N., Stoll R., Kucharzik T., Schmid K. W., Rohlmann G., Burmeister G., Sorg C., Domschke W. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion. 1995;56(5):406–414. doi: 10.1159/000201267. [DOI] [PubMed] [Google Scholar]
  70. Lügering N., Stoll R., Schmid K. W., Kucharzik T., Stein H., Burmeister G., Sorg C., Domschke W. The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest. 1995 Sep;25(9):659–664. doi: 10.1111/j.1365-2362.1995.tb01982.x. [DOI] [PubMed] [Google Scholar]
  71. Madsen P., Rasmussen H. H., Leffers H., Honoré B., Dejgaard K., Olsen E., Kiil J., Walbum E., Andersen A. H., Basse B. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol. 1991 Oct;97(4):701–712. doi: 10.1111/1523-1747.ep12484041. [DOI] [PubMed] [Google Scholar]
  72. McNamara M. P., Wiessner J. H., Collins-Lech C., Hahn B. L., Sohnle P. G. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet. 1988 Nov 19;2(8621):1163–1165. doi: 10.1016/s0140-6736(88)90234-6. [DOI] [PubMed] [Google Scholar]
  73. Meling T. R., Aabakken L., Røseth A., Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 1996 Apr;31(4):339–344. doi: 10.3109/00365529609006407. [DOI] [PubMed] [Google Scholar]
  74. Miyasaki K. T., Bodeau A. L., Murthy A. R., Lehrer R. I. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J Dent Res. 1993 Feb;72(2):517–523. doi: 10.1177/00220345930720020801. [DOI] [PubMed] [Google Scholar]
  75. Miyasaki K. T. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol. 1991 Dec;62(12):761–774. doi: 10.1902/jop.1991.62.12.761. [DOI] [PubMed] [Google Scholar]
  76. Moen O., Fosse E., Bråten J., Andersson C., Fagerhol M. K., Venge P., Høgåsen K., Mollnes T. E. Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation. Perfusion. 1994 Mar;9(2):109–117. doi: 10.1177/026765919400900205. [DOI] [PubMed] [Google Scholar]
  77. Murao S., Collart F. R., Huberman E. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J Biol Chem. 1989 May 15;264(14):8356–8360. [PubMed] [Google Scholar]
  78. Murthy A. R., Lehrer R. I., Harwig S. S., Miyasaki K. T. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol. 1993 Dec 1;151(11):6291–6301. [PubMed] [Google Scholar]
  79. Müller F., Frøland S. S., Aukrust P., Fagerhol M. K. Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. J Acquir Immune Defic Syndr. 1994 Sep;7(9):931–939. [PubMed] [Google Scholar]
  80. Müller F., Frøland S. S., Brandtzaeg P., Fagerhol M. K. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis. 1993 Feb;16(2):301–302. doi: 10.1093/clind/16.2.301. [DOI] [PubMed] [Google Scholar]
  81. Nacken W., Manitz M. P., Sorg C. Molecular characterisation of the genomic locus of the mouse MRP8 gene. Biochim Biophys Acta. 1996 Jan 17;1315(1):1–5. doi: 10.1016/0925-4439(95)00108-5. [DOI] [PubMed] [Google Scholar]
  82. Naess-Andresen C. F., Egelandsdal B., Fagerhol M. K. Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein). Clin Mol Pathol. 1995 Oct;48(5):M278–M284. doi: 10.1136/mp.48.5.m278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Naughton P. J., Clohessy P. A., Grant G., Pusztai A., Golden B. Faecal calprotectin: non-invasive marker of gastrointestinal inflammation in Salmonella infected rats. Biochem Soc Trans. 1996 May;24(2):308S–308S. doi: 10.1042/bst024308s. [DOI] [PubMed] [Google Scholar]
  84. Pekna M., Borowiec J., Fagerhol M. K., Venge P., Thelin S. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 1994;28(1):5–11. doi: 10.3109/14017439409098703. [DOI] [PubMed] [Google Scholar]
  85. Prydz H., Allison A. C. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost. 1978 Jun 30;39(3):582–591. [PubMed] [Google Scholar]
  86. Prydz H., Lyberg T., Deteix P., Allison A. C. In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins. Thromb Res. 1979;15(3-4):465–474. doi: 10.1016/0049-3848(79)90152-x. [DOI] [PubMed] [Google Scholar]
  87. Prydz H., Lyberg T. Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharmacol. 1980 Jan 1;29(1):9–14. doi: 10.1016/0006-2952(80)90236-1. [DOI] [PubMed] [Google Scholar]
  88. Raftery M. J., Harrison C. A., Alewood P., Jones A., Geczy C. L. Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem J. 1996 May 15;316(Pt 1):285–293. doi: 10.1042/bj3160285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Roth J., Goebeler M., Wrocklage V., van den Bos C., Sorg C. Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism. Biochem J. 1994 Aug 1;301(Pt 3):655–660. doi: 10.1042/bj3010655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Rugtveit J., Scott H., Halstensen T. S., Norstein J., Brandtzaeg P. Expression of the L1 antigen (calprotectin) by tissue macrophages reflects recent recruitment from peripheral blood rather than upregulation of local synthesis: implications for rejection diagnosis in formalin-fixed kidney specimens. J Pathol. 1996 Oct;180(2):194–199. doi: 10.1002/(SICI)1096-9896(199610)180:2<194::AID-PATH628>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  91. Røseth A. G., Aadland E., Jahnsen J., Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion. 1997;58(2):176–180. doi: 10.1159/000201441. [DOI] [PubMed] [Google Scholar]
  92. Røseth A. G., Fagerhol M. K., Aadland E., Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992 Sep;27(9):793–798. doi: 10.3109/00365529209011186. [DOI] [PubMed] [Google Scholar]
  93. Røseth A. G., Kristinsson J., Fagerhol M. K., Schjønsby H., Aadland E., Nygaard K., Roald B. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol. 1993 Dec;28(12):1073–1076. doi: 10.3109/00365529309098312. [DOI] [PubMed] [Google Scholar]
  94. Saintigny G., Schmidt R., Shroot B., Juhlin L., Reichert U., Michel S. Differential expression of calgranulin A and B in various epithelial cell lines and reconstructed epidermis. J Invest Dermatol. 1992 Nov;99(5):639–644. doi: 10.1111/1523-1747.ep12668098. [DOI] [PubMed] [Google Scholar]
  95. Sander J., Fagerhol M. K., Bakken J. S., Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest. 1984 Jun;44(4):357–362. doi: 10.3109/00365518409083820. [DOI] [PubMed] [Google Scholar]
  96. Santhanagopalan V., Hahn B. L., Dunn B. E., Weissner J. H., Sohnle P. G. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):285–290. doi: 10.1006/clin.1995.1127. [DOI] [PubMed] [Google Scholar]
  97. Santhanagopalan V., Hahn B. L., Sohnle P. G. Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. J Infect Dis. 1995 May;171(5):1289–1294. doi: 10.1093/infdis/171.5.1289. [DOI] [PubMed] [Google Scholar]
  98. Schmid K. W., Lügering N., Stoll R., Brinkbäumer P., Winde G., Domschke W., Böcker W., Sorg C. Immunohistochemical demonstration of the calcium-binding proteins MRP8 and MRP14 and their heterodimer (27E10 antigen) in Crohn's disease. Hum Pathol. 1995 Mar;26(3):334–337. doi: 10.1016/0046-8177(95)90067-5. [DOI] [PubMed] [Google Scholar]
  99. Semb A. G., Gabrielsen T. O., Halstensen T. S., Fagerhol M. K., Brandtzaeg P., Vaage J. Cardiac surgery and distribution of the leukocyte L1 protein-calprotectin. Eur J Cardiothorac Surg. 1991;5(7):363–367. doi: 10.1016/1010-7940(91)90053-m. [DOI] [PubMed] [Google Scholar]
  100. Sohnle P. G., Collins-Lech C., Wiessner J. H. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis. 1991 Jan;163(1):187–192. doi: 10.1093/infdis/163.1.187. [DOI] [PubMed] [Google Scholar]
  101. Sohnle P. G., Collins-Lech C., Wiessner J. H. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis. 1991 Jul;164(1):137–142. doi: 10.1093/infdis/164.1.137. [DOI] [PubMed] [Google Scholar]
  102. Sohnle P. G., Hahn B. L., Santhanagopalan V. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. J Infect Dis. 1996 Dec;174(6):1369–1372. doi: 10.1093/infdis/174.6.1369. [DOI] [PubMed] [Google Scholar]
  103. Sorg C. The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation. Behring Inst Mitt. 1992 Apr;(91):126–137. [PubMed] [Google Scholar]
  104. Steinbakk M., Naess-Andresen C. F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M. K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990 Sep 29;336(8718):763–765. doi: 10.1016/0140-6736(90)93237-j. [DOI] [PubMed] [Google Scholar]
  105. Stockley R. A., Dale I., Hill S. L., Fagerhol M. K. Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease. Scand J Clin Lab Invest. 1984 Nov;44(7):629–634. [PubMed] [Google Scholar]
  106. Svennevig J. L., Lunde O. C., Holter J. In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol Microbiol Immunol Scand A. 1982 Mar;90(2):131–137. doi: 10.1111/j.1699-0463.1982.tb00073_90a.x. [DOI] [PubMed] [Google Scholar]
  107. Söderquist B., Sundqvist K. G., Jones I., Holmberg H., Vikerfors T. Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with S. aureus septicemia. Scand J Infect Dis. 1995;27(4):375–380. doi: 10.3109/00365549509032734. [DOI] [PubMed] [Google Scholar]
  108. Teigelkamp S., Bhardwaj R. S., Roth J., Meinardus-Hager G., Karas M., Sorg C. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem. 1991 Jul 15;266(20):13462–13467. [PubMed] [Google Scholar]
  109. Ulvestad E., Williams K., Mørk S., Antel J., Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J Neuropathol Exp Neurol. 1994 Sep;53(5):492–501. doi: 10.1097/00005072-199409000-00008. [DOI] [PubMed] [Google Scholar]
  110. Umekawa T., Kurita T. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem Mol Biol Int. 1994 Sep;34(2):309–313. [PubMed] [Google Scholar]
  111. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Wick M. R., Mills S. E., Swanson P. E. Expression of "myelomonocytic" antigens in mesotheliomas and adenocarcinomas involving the serosal surfaces. Am J Clin Pathol. 1990 Jul;94(1):18–26. doi: 10.1093/ajcp/94.1.18. [DOI] [PubMed] [Google Scholar]
  113. Wilkinson M. M., Busuttil A., Hayward C., Brock D. J., Dorin J. R., Van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J Cell Sci. 1988 Oct;91(Pt 2):221–230. doi: 10.1242/jcs.91.2.221. [DOI] [PubMed] [Google Scholar]
  114. Wilson G. B., Fudenberg H. H., Jahn T. L. Studies on cystic fibrosis using isoelectric focusing. I. An assay for detection of cystic fibrosis homozygotes and heterozygote carriers from serum. Pediatr Res. 1975 Aug;9(8):635–640. doi: 10.1203/00006450-197508000-00005. [DOI] [PubMed] [Google Scholar]
  115. Wilson G. B., Jahn T. L., Fonseca J. R. Demonstration of serum protein differences in cystic fibrosis by isoelectric focusing in thin-layer polyacrylamide gels. Clin Chim Acta. 1973 Nov 23;49(1):79–91. doi: 10.1016/0009-8981(73)90346-x. [DOI] [PubMed] [Google Scholar]
  116. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  117. Yang Z., deVeer M. J., Gardiner E. E., Devenish R. J., Handley C. J., Underwood J. R., Robinson H. C. Rabbit polymorphonuclear neutrophils form 35S-labeled S-sulfo-calgranulin C when incubated with inorganic [35S]sulfate. J Biol Chem. 1996 Aug 16;271(33):19802–19809. doi: 10.1074/jbc.271.33.19802. [DOI] [PubMed] [Google Scholar]
  118. Yui S., Mikami M., Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J Leukoc Biol. 1995 Dec;58(6):650–658. doi: 10.1002/jlb.58.6.650. [DOI] [PubMed] [Google Scholar]
  119. Yui S., Mikami M., Yamazaki M. Purification and characterization of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin. J Leukoc Biol. 1995 Sep;58(3):307–316. doi: 10.1002/jlb.58.3.307. [DOI] [PubMed] [Google Scholar]
  120. Zwadlo G., Brüggen J., Gerhards G., Schlegel R., Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol. 1988 Jun;72(3):510–515. [PMC free article] [PubMed] [Google Scholar]
  121. van Calker D., Müller M., Hamprecht B. Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature. 1978 Dec 21;276(5690):839–841. doi: 10.1038/276839a0. [DOI] [PubMed] [Google Scholar]
  122. van Heyningen V., Dorin J. Possible role for two calcium-binding proteins of the S-100 family, co-expressed in granulocytes and certain epithelia. Adv Exp Med Biol. 1990;269:139–143. doi: 10.1007/978-1-4684-5754-4_22. [DOI] [PubMed] [Google Scholar]
  123. van Heyningen V., Hayward C., Fletcher J., McAuley C. Tissue localization and chromosomal assignment of a serum protein that tracks the cystic fibrosis gene. Nature. 1985 Jun 6;315(6019):513–515. doi: 10.1038/315513a0. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES